Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity

Nature Neuroscience

Volumn 12, Issue 7, 2009, Pages 839-847

  Woodhoo, Ashwin ^a   Alonso, Maria B Duran ^a   Droggiti, Anna ^a   Turmaine, Mark ^a   D'Antonio, Maurizio ^b   Parkinson, David B ^c   Wilton, Daniel K ^a   Al Shawi, Raya ^a   Simons, Paul ^a   Shen, Jie ^d   Guillemot, Francois ^e   Radtke, Freddy ^f   Meijer, Dies ^g   Feltri, M Laura ^b   Wrabetz, Lawrence ^b   Mirsky, Rhona ^a   Jessen, Kristján R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

^g ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NEU DIFFERENTIATION FACTOR; NOTCH RECEPTOR; ERBB2 PROTEIN, MOUSE; ERBB2 PROTEIN, RAT; GLYCOPROTEIN; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; NERVE PROTEIN; NRG1 PROTEIN, MOUSE; NRG1 PROTEIN, RAT; RBPSUH PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL CULTURE; CELL LINEAGE; CELL SIZE; CONTROLLED STUDY; EMBRYO CELL; MOUSE; MYELINATION; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SCHWANN CELL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; ANIMAL; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE; CYTOLOGY; DEMYELINATING DISEASE; GENETICS; GROWTH, DEVELOPMENT AND AGING; INJURY; METABOLISM; MYELIN SHEATH; NEURAL CREST; PERIPHERAL NERVE; PHYSIOLOGY; PRENATAL DEVELOPMENT; TIME;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DEMYELINATING DISEASES; EARLY GROWTH RESPONSE PROTEIN 2; GLYCOPROTEINS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; MICE; MICE, TRANSGENIC; MYELIN SHEATH; NERVE TISSUE PROTEINS; NEURAL CREST; NEUREGULIN-1; PERIPHERAL NERVES; RATS; RECEPTOR, ERBB-2; RECEPTORS, NOTCH; SCHWANN CELLS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 67649826154     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn.2323     Document Type: Article

References (38)

1. Jessen, K.R. & Mirsky, R. The origin and development of glial cells in peripheral nerves. Nat. Rev. Neurosci. 6, 671-682 (2005).
2. Woodhoo, A. & Sommer, L. Development of the Schwann cell lineage: from the neural crest to the myelinated nerve. Glia 56, 1481-1490 (2008).
3. Chen, Z.L., Yu, W.M. & Strickland, S. Peripheral regeneration. Annu. Rev. Neurosci. 30, 209-233 (2007).
4. Louvi, A. & Artavanis-Tsakonas, S. Notch signalling in vertebrate neural development. Nat. Rev. Neurosci. 7, 93-102 (2006).
5. Yoon, K. & Gaiano, N. Notch signaling in the mammalian central nervous system: insights from mouse mutants. Nat. Neurosci. 8, 709-715 (2005).
6. Lasky, J.L. & Wu, H. Notch signaling, brain development and human disease. Pediatr. Res. 57, 104R-109R (2005).
7. Bothwell, M. & Giniger, E. Alzheimer's disease: neurodevelopment converges with neurodegeneration. Cell 102, 271-273 (2000).
8. Jessen, K.R. & Mirsky, R. Negative regulation of myelination: relevance for development, injury and demyelinating disease. Glia 56, 1552-1565 (2008).
9. Scherer, S.S. & Salzer, J.L. Axonal-Schwann cell interactions during peripheral nerve degeneration and regeneration. in Glial Cell Development: Basic Principles and Clinical Relevance (eds. Jessen, K.R. & Richardson, W.D.) 299-330 (Oxford, New York, 2001). 10.Mü ller, H.W. & Stoll, G. Nerve injury and regeneration: basic insights and therapeutic interventions. Curr. Opin. Neurol. 11, 557-562 (1998).
10. Kubu, C.J. et al. Developmental changes in Notch1 and numb expression mediated by local cell-cell interactions underlie progressively increasing delta sensitivity in neural crest stem cells. Dev. Biol. 244, 199-214 (2002). 12.Wakamatsu, Y., Maynard, T.M. & Weston, J.A. Fate determination of neural crest cells by NOTCH-mediated lateral inhibition and asymmetrical cell division during gangliogenesis. Development 127, 2811-2821 (2000). 13.Morrison, S.J. et al. Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell 101, 499-510 (2000).
11. Bray, S.J. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol.7, 678-689 (2006).
12. Taylor, M.K., Yeager, K. & Morrison, S.J. Physiological Notch signaling promotes gliogenesis in the developing peripheral and central nervous systems. Development134, 2435-2447 (2007).
13. Jessen, K.R., Morgan, L., Stewart, H.J.S. & Mirsky, R. Three markers of adult nonmyelin- forming Schwann cells, 217c (Ran-1), A5E3 and GFAP: development and regulation by neuron-Schwann cell interactions. Development 109, 91-103 (1990). 17.Meier, C., Parmantier, E., Brennan, A., Mirsky, R. & Jessen, K.R. Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3 and platelet-derived growth factor- BB. J. Neurosci. 19, 3847-3859 (1999).
14. Brennan, A. et al. Endothelins control the timing of Schwann cell generation in vitro and in vivo. Dev. Biol. 227, 545-557 (2000).
15. Dong, Z. et al. Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation and maturation of rat Schwann cell precursors. Neuron 15, 585-596 (1995).
16. Birchmeier, C. & Nave, K.A. Neuregulin-1, a key axonal signal that drives Schwann cell growth and differentiation. Glia 56, 1491-1497 (2008).
17. Stewart, H.J., Morgan, L., Jessen, K.R. & Mirsky, R. Changes in DNA synthesis rate in the Schwann cell lineage in vivo are correlated with the precursor- Schwann cell transition and myelination. Eur. J. Neurosci. 5, 1136-1144 (1993).
18. Yu, W.M., Feltri, M.L., Wrabetz, L., Strickland, S. & Chen, Z.L. Schwann cell-specific ablation of laminin gamma1 causes apoptosis and prevents proliferation. J. Neurosci.25, 4463-4472 (2005). 23.Winseck, A.K. & Oppenheim, R.W. An in vivo analysis of Schwann cell programmed cell death in embryonic mice: the role of axons, glial growth factor, and the pro-apoptotic gene Bax. Eur. J. Neurosci. 24, 2105-2117 (2006). 24.Webster, H.D., Martin, R. & O'Connell, M.F. The relationships between interphase Schwann cells and axons before myelination: a quantitative electron microscopic study. Dev. Biol. 32, 401-416 (1973).
19. Topilko, P. et al. Krox-20 controls myelination in the peripheral nervous system. Nature371, 796-799 (1994).
20. Parkinson, D.B. et al. Regulation of the myelin gene periaxin provides evidence for Krox-20-independent myelin-related signaling in Schwann cells. Mol. Cell. Neurosci.23, 13-27 (2003).
21. Parkinson, D.B. et al. c-Jun is a negative regulator of myelination. J. Cell Biol. 181, 625-637 (2008).
22. Lemke, G. & Chao, M. Axons regulate Schwann cell expression of the major myelin and NGF receptor genes. Development 102, 499-504 (1988). 29.Morgan, L., Jessen, K.R. & Mirsky, R. The effects of cAMP on differentiation of cultured Schwann cells: progression from an early phenotype (04+) to a myelin phenotype (P0+, GFAP-, N-CAM-, NGF receptor-) depends on growth inhibition. J. Cell Biol. 112, 457-467 (1991).
23. Luo, D., Renault, V.M. & Rando, T.A. The regulation of Notch signaling in muscle stem cell activation and postnatal myogenesis. Semin. Cell Dev. Biol. 16, 612-622 (2005). 31.Martinez Arias, A., Zecchini, V. & Brennan, K. CSL-independent Notch signaling: a checkpoint in cell fate decisions during development. Curr. Opin. Genet. Dev. 12, 524-533 (2002).
24. Nave, K.A., Sereda, M.W. & Ehrenreich, H. Mechanisms of disease: inherited demyelinating neuropathies from basic to clinical research. Nat. Clin. Pract. Neurol. 3, 453-464 (2007).
25. Suter, U. & Scherer, S.S. Disease mechanisms in inherited neuropathies. Nat. Rev. Neurosci. 4, 714-726 (2003).
26. Svaren, J. & Meijer, D. The molecular machinery of myelin gene transcription in Schwann cells. Glia 56, 1541-1551 (2008). 35.Wang, S. et al. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21, 63-75 (1998). 36.Givogri, M.I. et al. Central nervous system myelination in mice with deficient expression of Notch1 receptor. J. Neurosci. Res. 67, 309-320 (2002).
27. John, G.R. et al. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 8, 1115-1121 (2002).
28. Li, Y. et al. Notch and Schwann cell transformation. Oncogene 23, 1146-1152 (2004).
29. Hatakeyama, J. et al. Hes genes regulate size, shape and histogenesis of the nervous system by control of the timing of neural stem cell differentiation. Development 131, 5539-5550 (2004).
30. Tanigaki, K. et al. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3, 443-450 (2002).
31. Jaegle, M. et al. The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development. Genes Dev. 17, 1380-1391 (2003).
32. Radtke, F. et al. Deficient Tcell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547-558 (1999).
33. Yang, X. et al. Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. Dev. Biol. 269, 81-94 (2004).
34. Feltri, M.L. et al. P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells. Ann. NY Acad. Sci. 883, 116-123 (1999).
35. Sharghi-Namini, S. et al. The structural and functional integrity of peripheral nerves depends on the glial-derived signal desert hedgehog. J. Neurosci. 26, 6364-6376 (2006).
36. D'Antonio, M. et al. TGFbeta type II receptor signaling controls Schwann cell death and proliferation in developing nerves. J. Neurosci. 26, 8417-8427 (2006).
37. D'Antonio, M. et al. Gene profiling and bioinformatic analysis of Schwann cell embryonic development and myelination. Glia 53, 501-515 (2006). 48.Rangarajan, A. et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J. 20, 3427-3436 (2001).
38. Jessen, K.R., Morgan, L., Brammer, M. & Mirsky, R. Galactocerebroside is expressed by non-myelin-forming Schwann cells in situ. J. Cell Biol. 101, 1135-1143 (1985). 50.Morgan, L., Jessen, K.R. & Mirsky, R. Negative regulation of the P0 gene in Schwann cells: suppression of P0mRNA and protein induction in cultured Schwann cells by FGF2 and TGF beta 1, TGF beta 2 and TGF beta 3. Development 120, 1399-1409 (1994).